Methylphenidate Extended-Release Tablets and Perflutren Protein Type A
Determining the interaction of Methylphenidate Extended-Release Tablets and Perflutren Protein Type A and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren, Perflutren Lipid Microspheres
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Methylphenidate Extended-Release Tablets-Perflutren protein type a microsphere Intravenous
- Methylphenidate Extended-Release Tablets-Perforomist
- Methylphenidate Extended-Release Tablets-Perforomist, Symbicort
- Methylphenidate Extended-Release Tablets-Pergolide
- Methylphenidate Extended-Release Tablets-Pergonal
- Methylphenidate Extended-Release Tablets-Peri-Colace
- Perflutren Protein Type A-Methylphenidate Hydrochloride
- Perflutren Protein Type A-Methylphenidate LA Capsules
- Perflutren Protein Type A-Methylphenidate Oral Solution
- Perflutren Protein Type A-Methylphenidate Oral, Transdermal
- Perflutren Protein Type A-Methylphenidate Tablets
- Perflutren Protein Type A-Methylphenidate transdermal